Hong Kong health authorities have apologised for mistakenly giving pneumococcal vaccines to two children at a health centre ...

Reports Q4 revenue $73.0M, consensus $72.7M. “In 2024, we successfully executed on our strategic growth initiatives, achieving record ...

Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

Four-year results of a phase III trial showed that budesonide oral suspension (Eohilia) for eosinophilic esophagitis was well ...

"We were delighted to discover not only important details about the mechanisms of HBV gene regulation, but also a promising ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...

Deep Track, a Greenwich, Ct., investment management company that holds 13.5% of Dynavax's stock, pointed its finger at ...

The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.

From the bright lights and buzzy nightlife of Bangkok to some of Asia's most spectacular beaches, this is how to get the most ...

Life sciences investment firm Deep Track Capital is launching a board fight at Dynavax Technologies, pressing for new directors to prioritize the development of the company's hepatitis B vaccine ...